With this approval, the total addressable market size of the company's approved ANDAs is estimated to be a little above $ 300 million
According to the Ministry, India's pharma exports grew from $ 11.66 billion to $ 12.54 billion in 2015, while China increased its exports from $ 6.59 billion to $ 6.94 billion
Acquisition will enable Evonik to consolidate its position in the market of probiotics, which are living microorganisms that have a positive effect on the gastro-enteric system of animals
The approved product is generic equivalent of Takeda's Uloric, which has an estimated market size of $ 430 million for twelve months ending December 2015
Two sides will collaborate to provide effective healthcare delivery at the last mile by reducing uncertainty in critical infrastructure, particularly electricity, via cost effective solar-based soluti
Kalundborg facility produces 50 percent of the world's insulin as well as a range of biopharmaceutical products
However, the company has received two minor observations from the US drug regulator for its Waluj (Maharashtra) facility
The patent, granted for process of manufacturing water soluble film (WSF) system with embedded/entrapped actives, has wide applications in pharma and agrochemicals industries
The company says the inspection was completed without issuance of Form 483, which is issued by US FDA for violations of good manufacturing practices
The acquisition will help Torrent Pharma in vertically integrating its abbreviated new drug application (ANDA) filings in the future
The augmentation of Sunrex facilities, when completed in November 2017, will bring Mitsui Chemicals global production capacity to 115,000 tonnes per annum
Acquisition will expand portfolio of Evonik's healthcare business line with liposomal formulation technologies for parenteral drugs
The production capacity of Siegfried's Nantong site, located in China's industrial park northwest of Shanghai, amounts to 350 cubic meters
Tenepan (teneligliptin) is recommended to use in newly diagnosed patients and as an add-on therapy in patients uncontrolled on metformin or sulfonylurea therapy
The settlement allows Teva to commercialise its generic version of AstraZeneca's Byetta (exenatide injection) in the US beginning October 15, 2017
While Boehringer Ingelheim will transfer its CHC business to Sanofi, in return it will get Sanofi's animal health business Merial. In addition, Boehringer Ingelheim will pay Sanofi Euro 4.7 bn
Through the tie-up with Labo Cosprophar, the Mumbai-based pharmaceutical company will launch two new products for hair and skin care
The European Medicines Agency (EMA), which is headquartered in the UK, is likely to be swiftly relocated to the EU, says GlobalData in a whitepaper
With more mature ecosystem and ample opportunities, Indians today are not only launching their own brands but also making their mark globally, says Umang Srivastav
The government has decided to comprehensively review the existing law with objectives of facilitating the ease of doing business and enhancing the quality of Indian pharma products